{"database": "lobbying", "table": "lobbying_activities", "rows": [[2871859, "ce4ba80b-6819-4da7-a33f-4c122284d93b", "Q3", "LINCOLN PARK GROUP L.L.C.", 401104374, "CANADIAN INTERNATIONAL PHARMACY ASSOCIATION", 2022, "third_quarter", "PHA", "Support for S. 920/H.R. 2181 - A bill to amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals and S. 259/H.R. 832 - Safe and Affordable Drugs from Canada Act; S. 3399/H.R. 6532 Domain Reform for Unlawful Drug Sellers Act; S. 3984, Stop Illegal Online Sales of Controlled Substances Act; and other issues related to personal drug importation.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2022-10-18T15:00:58-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2871859"], "units": {}, "query_ms": 5.679554073140025, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}